Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

June 19, 2024

Iambic secures $50m to bolster clinical oncology programme pipeline

Clinical-stage biotechnology company Iambic Therapeutics has secured $50m in its Series B extension financing round to bolster its pipeline comprising artificial intelligence (AI)-discovered clinical oncology programmes.

Iambic secures $50m to bolster clinical oncology programme pipeline